BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21613357)

  • 1. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.
    Broer SL; Eijkemans MJ; Scheffer GJ; van Rooij IA; de Vet A; Themmen AP; Laven JS; de Jong FH; Te Velde ER; Fauser BC; Broekmans FJ
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2532-9. PubMed ID: 21613357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
    Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
    Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study.
    Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT
    Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.
    Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ
    J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
    van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER
    Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline.
    de Kat AC; van der Schouw YT; Eijkemans MJ; Herber-Gast GC; Visser JA; Verschuren WM; Broekmans FJ
    BMC Med; 2016 Oct; 14(1):151. PubMed ID: 27716302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of measuring anti-Müllerian hormone in predicting menopause.
    Aydogan B; Mirkin S
    Climacteric; 2015; 18(6):777-89. PubMed ID: 25845388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
    Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
    Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
    La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A
    BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling age at menopause using serum concentration of anti-mullerian hormone.
    Tehrani FR; Solaymani-Dodaran M; Tohidi M; Gohari MR; Azizi F
    J Clin Endocrinol Metab; 2013 Feb; 98(2):729-35. PubMed ID: 23316087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.
    Freeman EW; Sammel MD; Lin H; Gracia CR
    J Clin Endocrinol Metab; 2012 May; 97(5):1673-80. PubMed ID: 22378815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer.
    Anderson RA; Cameron DA
    J Clin Endocrinol Metab; 2011 May; 96(5):1336-43. PubMed ID: 21325458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone.
    Gohari MR; Ramezani Tehrani F; Chenouri S; Solaymani-Dodaran M; Azizi F
    Menopause; 2016 Aug; 23(8):839-45. PubMed ID: 27326817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.
    Kim C; Slaughter JC; Wang ET; Appiah D; Schreiner P; Leader B; Calderon-Margalit R; Sternfeld B; Siscovick D; Wellons M
    Maturitas; 2017 Aug; 102():18-25. PubMed ID: 28610678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
    Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.